Results 241 to 250 of about 15,476,282 (336)
A molecular‐bridging heterogeneous interface engineering strategy is introduced to combine a polyhedral oligomeric silsesquioxane (POSS)‐based hard coating with a colorless polyimide (CPI)‐based flexible layer. The robust heterogeneous interface endows the integrated system with the superior properties of both layers and their synergistic ...
Huiyang Lu +5 more
wiley +1 more source
Point-of-care ClotPro thromboelastography to determine bleeding risk in two cats with factor XII deficiency. [PDF]
Forer V +5 more
europepmc +1 more source
Coagulation factor XII (Hageman factor)
Georg Dewald, Konrad Bork
openaire +1 more source
An MXene‐based flexible piezoresistive sensor featuring a multi‐stage microdome architecture is developed, which simultaneously realizes high sensitivity of 11.57 kPa−1 and an ultra‐broad detection range up to 2500 kPa. When integrated into palm and sole sensor arrays combined with deep learning algorithms, it achieves a recognition accuracy of over 95%
De‐Yu Kong +9 more
wiley +1 more source
Surface Modification of Poly(dimethylsiloxane) Blood Flow Chambers with a Poly(ethylene glycol) Conjugate and Factor XII Inhibitor. [PDF]
DeMeulemeester JA +2 more
europepmc +1 more source
Schematic illustration of injectable PDA‐modified GelMA microspheres loaded with BioPre‐Exos for vascularized bone regeneration. ABSTRACT Critical‐sized bone defects remain a highly challenging clinical problem due to insufficient intrinsic self‐healing capacity.
Lijun Li +9 more
wiley +1 more source
This study demonstrates significantly reduced Lkb1 expression in CD11c+ cells in chronic pancreatitis (CP) patients and animal models. Lkb1 deletion enhances CD11c+CD206+ macrophage infiltration and reprograms pancreatic stellate cells (PSCs) via OSM signaling.
Wenqing Zhang +10 more
wiley +1 more source
ABSTRACT Blood‐based liquid biopsies hold transformative potential for non‐invasive cancer management, but current approaches relying on rare circulating tumor components limit their broad clinical utility. Platelets, abundant in blood and mediating diverse cancer‐associated responses, represent a compelling yet largely unexplored alternative.
Yan Ma +28 more
wiley +1 more source
A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation. [PDF]
Xu P +16 more
europepmc +1 more source

